Journal profile · Oncology
Journal of Cancer Research and Clinical Oncology
ISSN 0171-5216 · eISSN 1432-1335 · Springer Berlin Heidelberg · GERMANY · Monthly · Founded 1904
Journal of Cancer Research and Clinical Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.26; fully open access; APC about USD 4,390; median 55 days to acceptance (82 articles, last 24 months); community-reported acceptance: about 54.16%; 327 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Cancer Research and Clinical Oncology is published by Springer Berlin Heidelberg and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Medical and Health Sciences Research, together about 19.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the German Cancer Society (Deutsche Krebsgesellschaft) The Journal of Cancer Research and Clinical Oncology contains significant and up-to-date articles within the fields of experimental and clinical oncology. The following topics are covered:Carcinogenesis – etiology, mechanisms • Molecular biology • Recent developments in tumor therapy • General diagnosis • Laboratory diagnosis • Molecular diagnosis – diagnostic and experimental pathology • Oncologic surgery • Epidemiology – precision medicine, targeted therapy, immuno-oncology, artificial intelligence.
From the journal's Aims & Scope
Research area (LetPub): Oncology
Editor-in-chief Alwin KraPublisher website
Editorial board by country: 10 in mainland China (about 23%); most named Germany 27, Mainland China 10, United States 3, Japan 1, South Korea 1 (43 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lung Cancer Treatments and MutationsMedicine8.1%
- Cancer Immunotherapy and BiomarkersMedicine6.7%
- Medical and Health Sciences ResearchMedicine4.8%
- Cancer Cells and MetastasisMedicine4.7%
- Ferroptosis and cancer prognosisMedicine4.4%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine4.3%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology4.2%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.26LetPub ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 6.4LetPub ·
- SJR 2026-06
- 0.95LetPub ·
- SNIP 2026-06
- 0.82LetPub ·
- h-index
- 87LetPub ·
- h-index
- 137OpenAlex ·
- i10-index
- 6,615OpenAlex ·
- 2-year mean citedness
- 4.98OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 63.18%LetPub ·
Volume
- Articles per year
- 290LetPub ·
- Downloads per year (publisher) 2025
- 2,600,000Publisher website ·
Articles by year OpenAlex count · 17,268 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 210 | 210 | 54 |
| 2025 | 327 | 327 | 1,003 |
| 2024 | 544 | 544 | 4,330 |
| 2023 | 975 | 975 | 8,722 |
| 2022 | 655 | 655 | 8,843 |
| 2021 | 392 | 391 | 7,191 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
55 daysMedian, submission to acceptance · P25–P75 34 days – 81 days
- Acceptance to online
- median 20 days (82 articles)
- Submission to online
- median 76 days
- Sample
- 82 articles with submission and acceptance dates (655 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 54.16%LetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,290 / USD 4,390 / GBP 2,790 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 4,390 / EUR 3,290 / GBP 2,790 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 5,000 words
- Reference style
- Author–date
- Suggested reviewers
- Optional
Article types accepted11
- case reportOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- commentaryOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review proce…Length not stated
- letter to the editorOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- literature reviewOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- matters arisingMatters Arising articles are formal post-publication scientific commentaries on papers published in the journal; they can include either challenges or clarifica…Length not stated
- original articleOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- original articlesManuscripts must contain a structured abstract (max. 250 words) including headings: Purpose (stating the main purposes and research question), Methods, Results,…Length not stated
- reviewOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- review articleOriginal ArticlesReview ArticlesLetter to the EditorCase Based ReviewMatters Arising • Original Articles Manuscripts must contain a structured abstract (max. 25…Length not stated
- review articlesManuscripts must contain an unstructured abstract (max. 250 words). Word limit 5,000 words, no more than 4 tables and figures (combined total), no more than 100…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Generative AI Images
LLMs do not satisfy authorship criteria; use must be documented in Methods Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data Availability
Optional data availability statement Model summary
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Articles in Springer Nature open access journals do not require transfer of copyright as the copyright remains with the author. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
ORCID required for corresponding author Model summary
To find out more about publishing your work Open Access in Journal of Cancer Research and Clinical Oncology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review Single-blind peer review
Single-blind peer review Model summary
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process.
Source ↗Publisher website ·- Preprints
Preprint DOI citation as footnote to title Model summary
Authors must cite the DOI of a pre-print publication as a footnote to the title, if applicable.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Berlin Heidelberg
- Country or region
- GERMANY
- Language
- English
- Frequency
- Monthly
- Founded
- 1904
- ISSN
- 0171-5216
- Electronic ISSN
- 1432-1335
- Society / sponsor
- German Cancer Society
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Cancer Research and Clinical Oncology
What CAS zone is Journal of Cancer Research and Clinical Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Cancer Research and Clinical Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Cancer Research and Clinical Oncology?
The latest impact factor listed by LetPub is 3.26; CiteScore 6.4, h-index 137.
How long does peer review take at Journal of Cancer Research and Clinical Oncology?
Based on the dates recorded on 82 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 55 days (interquartile range 34–81 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 54.16%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of Cancer Research and Clinical Oncology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 5,000 words; Reference style: Author–date; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of Cancer Research and Clinical Oncology based?
Of the 43 board members whose country the journal's board page names, 10 (about 23%) are in mainland China; the countries named most often are Germany (27), Mainland China (10) and United States (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Cancer Research and Clinical Oncology?
According to LetPub and DOAJ records, Journal of Cancer Research and Clinical Oncology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Journal of Cancer Research and Clinical Oncology open access, and what is the APC?
Journal of Cancer Research and Clinical Oncology is a fully open-access journal. APC about USD 4,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .